Battle over $7.25 bln Roundup settlement takes a new turn as Supreme Court decision looms
A federal judge has rejected efforts to slow the progress of a $7.25 billion class action settlement in the nationwide Roundup cancer litigation, notching a win for Roundup maker Bayer but frustrating a group of plaintiffs’ attorneys who claim the deal is unfair to cancer patients.
